Adequate tumour models are a preqste in rimental cancer rsarch. The purpose of the prst work was to taablsh and asess the valty of four new orthotopic human melanoma xenograft model systems (A-07, D-12, R-18, U-25). Pomnent (Fidler, 1991; Fu et al., 1991) . Moreover, cellular treatment sensitivity is probably retained during serial transplantation of some human tumours in immune-deficient mice (Rofstad, 1992a Hill. 1990 ), but are strongly modified by angiogenic and pathophysiological parameters of the tumour tissue (Folkman, 1985; Vaupel et al., 1989 (Table I) .
, whereas experimental human tumours are supposed to model adequately the secific neoplastic disease of the donor patient (Suthrlrand et al., 1988) . The availability of congenitally athymic mice and severe combined immune deficiency mice has resulted in increased use of human tumour xenografts in cancer research the last two decades. Recent studies have indicated that orthotopic heterotransplantation of human tumours may result in metastatic patterns in mice similar to those observed in man (Fidler, 1991; Fu et al., 1991) . Moreover, cellular treatment sensitivity is probably retained during serial transplantation of some human tumours in immune-deficient mice (Rofstad, 1992a) . No single xenograft model can be expected to be appropriate for all types of questions related to a specific neoplastic disease; a panel of models of the same histopathological type is required (Kallman et al., 1985) . A xenograft panel is parficularly useful if it is composed of tumour lines that differ substantially in their biological characteristics and at the same time reflt the biology of the donor patients' tumours. Moreover, the xenografted tumours should have disaggregation and growth properties making them suitable for studies in vitro as well as in vivo.
Four new orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern are reported in the present communication. Tumour treatment sensitivity and metastatic pattern are governed by intrinsic properties of the tumour cells Hill. 1990 ), but are strongly modified by angiogenic and pathophysiological parameters of the tumour tissue (Folkman, 1985; Vaupel et al., 1989 (Nagelhus & Rofstad, 1993) . Polyclonal rabbit anti-factor VIII (Dakopatts), polyclonal rabbit anti-laminin (Serotec), polyclonal rabbit anti-fibronectin (Calbiochem) and monoclonal mouse anti-type IV collagen (Dakopatts) were used as primary reagents. The sections were stained by using diaminobenzidine as substrate and haematoxylin for counterstaining. Murine host cells in xenografted tumours were identified by using the bisbenzimide staining technique (Rygaard, 1987) .
Vascular density was assessed at a magnification of x 200 by counting number of capillary profiles per field of view, corresponding to 0.75 mm2. A structure was defined as a countable capillary only if a lumen and at least one brownstaining endothelial cell were identified. Volume fraction of necrosis was determined by point counting (Solesvik et al., 1982) . Five fields of view, selected according to stringent stereological criteria (Weibel, 1979) , were analysed in each of 4-6 different tumour pieces from each patient.
Ultrastructural examinations
The ultrastructure of microvessels in xenografted tumours was examined by transmission electron microscopy. Tumour pieces were fixed in a cacodylate-buffered mixture of 1% glutaraldehyde and 4% paraformaldehyde, post-fixed in buffered 1% osmium tetroxide and dehydrated in graded alcohol solutions. The tissue was embedded in EponAraldite and polymerised at 80C. Ultrathin sections were double stained with uranyl acetate and lead citrate.
Cell suspensions Single-cell suspensions were prepared from donor patients' tumours and xenografted tumours by using a standardised mechanical and enzymatic procedure. The tumour tissue was minced with crossed scalpels in cold HBSS prior to enzymatic treatment at 37C for 2 h. The enzyme solution consisted of 0.2% collagenase, 0.05% pronase and 0.02% DNAse in HBSS. The fraction of contaminating diploid host cells in the suspensions, determined by flow cytometry, was low for both donor patients' tumours (<10%) and xenografted tumours (<1%). The fraction of morphologically intact tumour cells, determined by trypan blue exclusion, was always high (> 80%). Cell aggregates were removed from the suspensions by filtration through 30 gm nylon mesh.
Floe cytometry
An Argus Skatron flow cytometer, equipped with an arch lamp as excitation source, was used for measurements of DNA histograms. Suspensions of clean cell nuclei were prepared from single-cell suspensions and stained with propidium iodide according to the detergent-trypsin method (Vindel0v et al., 1983) . Excitation of propidium iodide was accomplished by using the 546 nm mercury line. Fluorescence was detected at wavelengths above 590 nm. Chicken and trout red blood cells were used as internal reference standards. DNA index was calculated by using human lymphocytes as diploid reference. The DNA histograms were analysed mathematically to determine the distribution of cells in the cell cycle (Dean & Jett, 1974) .
Single cells. kept in suspension in RPMI-1640 culture medium at pH 7.4. were treated with radiation (2.0 Gy). heat (43.5'C for 60min) or dacarbazine (1 x lO3jgml-' for 60 min). Radiation treatment was carried out under aerobic conditions at room temperature at a dose rate of 3.4 Gy mini'. The X-ray unit was operated at 220 kV. 20 mA and with 0.5 mm copper filtration (Rofstad. 1992b) . Heat treatment was performed by using a thermostatically regulated water bath. To avoid enhancement of the cell inactivation by the enzymes used for the preparation of single-cell suspensions. the cells were incubated at 37°C in an atmosphere of 5% carbon dioxide in air for 3 h prior to the heat exposure (Rofstad. 1992a) . Dacarbazine treatment was given by incubating the cells at 37°C in an atmosphere of 5% carbon dioxide in air in the presence of the drug. The cells were washed in Ca2'-and Mg'+-free HBSS after treatment.
Cell survival was measured by using a soft-agar colony assay (Courtenay & Mills. 1978 (Rofstad et al.. 1987) . Macrophages are the only host cells that form colonies in the assay. The loosely packed macrophage colonies were easily distinguished from the densely packed melanoma colonies. Melanoma colonies containing more than 50 cells were counted by using a stereomicroscope (Rofstad et al., 1987) . The PE of trypan blue excluding melanoma cells was 10-25% (donor patients' tumours). 10-40% (xenografted tumours) and 80-95% (monolayer cultures).
Angiogenesis
Tumour angiogenesis was assessed by using the intradermal angiogenesis assay (Kreisle & Ershler. 1988; Runkel et al.. 1991) . Approximately 3.5 x I0-cells, harvested from cultures in exponential growth, were inoculated intradermally in the flanks of mice as described above. The skin around the inoculation sites was removed at predetermined times after the inoculation. The tumours were located with a dissecting microscope, and angiogenesis was quantified by counting the number of capillaries oriented toward the tumours. The number of capillaries was corrected for the background, determined after injection of 10tLI of HBSS. The tumours were dissected free from the skin and weighed after the capillaries were scored.
Metastatic pattern Intradermal tumours. 30 of each of the four lines, were initiated in 120 mice as described above. The tumours were removed surgically as soon as the largest tumour diameter attained 1O mm. and the wounds were closed with surgical clips. The mice were killed and autopsied 6 months after the primary tumour was removed or when they were moribund. All organs were examined for macroscopic metastases. Lungs, axial and inguinal lymph nodes. brain, kidneys. Significant differences between the four tumours were not detected. They were all judged to be highly malignant by histopathological critenra. The donor patients' tumours were also heterogeneous in growth and pathophysiological parameters (Table II) 
Growth of cell lines
The four cell lines were characterised by extensive cellular pleomorphism. Most cells were polygonal or spindle shaped and showed abundant cytoplasm and large irregular nuclei with prominent nucleoli. DNA index differed significantly between the cell lines, whereas most growth parameters were similar (Table III) . The cell lines were hyperdiploid: DNA index ranged from 1.1 ± 0.1 to 1.8 ± 0.1. Growth fraction was high (>90%) and cell loss factor was low (< Oo%) during exponential growth. The cell lines formed easily scorable colonies within 7-10 days after plating and showed a high PE (>80%). Median cell cycle time dunrng exponential growth, calculated from cell number doubling time. growth fraction and cell loss factor. was slightly longer for the R-18 and U-25 lines than for the A-07 and D-12 lines (P < 0.05). The angiogenic response was heterogeneous also for cells of the same line (Figure 3 ). This heterogeneity was reflected in the rate of angiogenesis and in the density of the neovas- culature. The number of capillaries oriented towards the tumours at day 7 after inoculation was used as a parameter for the rate of angiogenesis (Figure 3a) . The number of capillaries oriented toward the tumours at tumour weights of approximately 30 mg was used as a parameter for the density of the neovasculature (Figure 3b ). The latter parameter might also reflect the capillary density within the 30 mg tumours.
Histopathology, growth and pathophysiology of xenografted twnours The xenografted tumours were deposited above the subcutaneous muscle tissue in the deeper part of the dermis, and were not circumscribed by a fibrous capsule (Figure 4a 
Metastatic pattern ofxenografted tunours
The xenografted tumours showed organ-specific metastatic patterns (Table IV) . The orgn of preference for the development of metastases were lungs for A-07 and D-12 tumours (Figure 7a ), lymph nodes for R-18 tumours ( Figure  7b ) and brain for U-25 tumours (Figure 7c) . A-07 tumours grew faster and were more angiogenic than D-12 tumours, but did not metastasise more frequently than D-12 tumours. U-25 tumours grew more slowly and were less angiogenic than A-07, D-12 and R-18 tumours, but were the only ones that formed brain metastases. R-18 lymph node metastases and U-25 brain metastases developed without the occurrence of lung metastases. Approximately 15% of the mice developed organ-specific metastases within 6 months after the inoculation of the primary tumour. In addition, approximately 10% of the mice developed abdominal metastases. Different organs in the abdomen were involved, particularly adrenal glands, pancreas, liver and kidneys (Figure 7d ). In contrast, xenografted tumours grown at subcutaneous sites did not develop organ-specific or abdominal metastases.
Treatment sensitivity of donor patients' twnours, cell lines and renografted tumours The donor patient's tumour, the corresponding cell line and the corresponding xenografted tumours showed similar sensitivities to treatment in vitro, no matter which line or treatment modality was considered (Table V) . The sensitivity to a given treatment differed substantially between the lines. There were no correlations between the sensitivity to radiation treatment, heat treatment and dacarbazine treatment. The sequences of the lines from high to low cel surviving fractions following treatment were: R-18, U-25, A-07, D-12 (radiation treatment); D-12, R-18, U-25, A-07 (heat treatment); and U-25, A-07, R-18, D-12 (dacarbazine treatment).
Human tumour xenografts are supposed to be appropriate models for addressing specific questions related to the clinical (Langdon & Smyth, 1991) ; vascular and microenvironmental parameters (Vaupel et al., 1987) ; sensitivity to drug, radiation and heat treatment (Steel et al., 1983; Rofstad, 1989a) ; and growth pattern and metastatic potential (Fidler, 1990 ). However, biological conditions which may limit the usefulness of human tumour xenografts in cancer research have also been recognised. Thus, the vascular network and the blood of xenografted tumours orginate from the host, a fact which may cause the oxygen and nutrient supply to differ from that in tumours in man (Solesvik et al., 1982) . Moreover, immune reactions by the host may be active against xenografted tumours and artificially enhance the response to treatment (Rofstad, 1989b (Kallman et al., 1985; Sutherland et al., 1988; Rofstad, 1991 (Fxiler, 1990) . Orthotopic inoculation seems to be particularly imxportant for accurate reproduction of the metastatic behaviour of human tumours (Fidler, 1991) . Thus, intradermal inoculation of human melanoma cells in athymic mice resulted in primary tumours that metastasised at high frequency to draining lymph nodes, wlhreas the primary tumours that developed after subcutaneous inoculation of the same cells rarely gave rise to lymph node meastases (Cornil et al., 1989 Cell line (2.5 ± 0.4) x 10-' (1.6 ± 0.7) x 10-' (2.2 ± 0.9) x 10-Xenograft (2.2±0.5)x 10' (l.9±0.9)x 10-' (2.8±0.7)x 10-' D-12 Patient's tumour (1.5 ± 0.4) x 10' (7.5 ± 0.9) x 10' (4.9 ± 1.0) x 10-2 Cell hne (1.3 ± 0.4) x 10-(7.4 ± 0.6) x 10-' (4.0± 1.2) x 10-2 Xenograft (1.7 ± 0.5) x 10-' (7.0± 0.8) x 10-' (4.4 ±0.9) x 10-2 R-18
Patient's tumour (4.5 ± 0.7) x 10-(5.4 ± 0.7) x 10-' (8.1 ± 1.2) x 10-2
Cell lne (4.9 ± 0.5) x 10-' (5.1 ± 0.9) x 10-' (9.5 ± 1.3) x 10-2 Xenograft (4.4 ± 0.6) x 10-' (5.8 ± 0.8) x 10-' (8.9 ± 1.0) x 10-2 U-25
Patient's tumour (3.6 ± 0.6) x 10-' (3.7 ± 0.9) x 10-' (6.0 ± 1.0) x 10-'
Cell fine (3.1 ±0.7) x 10-' (3.9 0.8) x 10-1 (6.9 0.8) x 10-' Xenograft (3.9 ± 0.8) x 10-(3.3 ± 0.6) x 10-1 (6.4 ± 0.8) (Folkman, 1985; Sutherland et al., 1988; Vaupel et al., 1989; Hill, 1990) . The melanoma xenograft model systems may thus be utilised to establish correlations between pathophysiological parameters and parameters characterising tumour treatment response or metastatic behaviour, and to investigate whether correlations are valid across tumour lines or whether different correlations exist for tumour lines differing in intrinsic cel-lular properties (Rofstad et al., 1988) . The development of in vitro and/or in vivo assays for prediction of response to treatment or metastatic behaviour of malignant melanoma may be guided by investigations of this type (Rofstad, 1989c) .
Xenografted tumours and monolayer cell cultures showed growth properties and treatment sensitivities that render a wide variety of experiments possible. Cell lines evoking a strong angiogenic response in vivo formed tumours with short volume doubling times and high fractions of cells in S-phase and vice versa. Disaggregated xenografted tumours developed easily scorable colonies at high PE in vitro. The established cell lines showed short cell cycle times, growth fractions close to 100% and negligible cell loss factors during exponential growth. Cellular sensitivity to radiation, heat and dacarbazine treatment was similar for xenografted tumours and monolayer cell cultures. Consequently, studies of xenografted tumours and monolayer cell cultures may complement one another in attempts to acquire increased knowledge of the biology of malignant melanoma.
In conclusion, the melanoma xenograft panel reported here is composed of tumour lines which have retained essential biological features of the donor patients' tumours, show distinctly different biological characteristics and possess growth qualities making them well suited for experimental studies in vivo and in vitro. The four orthotopic tumour model systems thus show great promise for future studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern.
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